Sodium nucleinate clinical trials
How each study uses sodium nucleinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the sodium nucleinate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2022 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
MIPO Clinic (5)
Studies
Open first, then newest update. How each study uses sodium nucleinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Immune-Mitochondrial Correction in Military RecruitsNot yet recruitingNot applicableMIPO ClinicNCT07622147Written as Sodium nucleinate combination
- Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant DiseasesCompletedPhase 2/3MIPO ClinicNCT07671508Written as Naderin
- Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer ChemotherapyCompletedPhase 2/3MIPO ClinicNCT07671547Written as Naderin
- Immunosurveillance for Metastatic Colorectal CancerCompletedPhase 2/3MIPO ClinicNCT06509880Written as Adenorine
- Role of Neutrophils and Electro-bioluminescence in the RehabilitationCompletedPhase 1MIPO ClinicNCT06209229Written as sodium nucleinate
Codes
What other systems call sodium nucleinate · ClinicalTrials.gg INT002586
- MeSH (NLM) C013683sodium nucleinateOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C013683 | sodium nucleinate | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.